162 related articles for article (PubMed ID: 32220323)
41. Searching for predictive blood biomarkers: misfolded p53 in mild cognitive impairment.
Stanga S; Lanni C; Sinforiani E; Mazzini G; Racchi M
Curr Alzheimer Res; 2012 Dec; 9(10):1191-7. PubMed ID: 22746246
[TBL] [Abstract][Full Text] [Related]
42. Small RNA Sequencing across Diverse Biofluids Identifies Optimal Methods for exRNA Isolation.
Srinivasan S; Yeri A; Cheah PS; Chung A; Danielson K; De Hoff P; Filant J; Laurent CD; Laurent LD; Magee R; Moeller C; Murthy VL; Nejad P; Paul A; Rigoutsos I; Rodosthenous R; Shah RV; Simonson B; To C; Wong D; Yan IK; Zhang X; Balaj L; Breakefield XO; Daaboul G; Gandhi R; Lapidus J; Londin E; Patel T; Raffai RL; Sood AK; Alexander RP; Das S; Laurent LC
Cell; 2019 Apr; 177(2):446-462.e16. PubMed ID: 30951671
[TBL] [Abstract][Full Text] [Related]
43. Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine.
Blasko I; Jellinger K; Kemmler G; Krampla W; Jungwirth S; Wichart I; Tragl KH; Fischer P
Neurobiol Aging; 2008 Jan; 29(1):1-11. PubMed ID: 17055615
[TBL] [Abstract][Full Text] [Related]
44. Altered DNA base excision repair profile in brain tissue and blood in Alzheimer's disease.
Lillenes MS; Rabano A; Støen M; Riaz T; Misaghian D; Møllersen L; Esbensen Y; Günther CC; Selnes P; Stenset VT; Fladby T; Tønjum T
Mol Brain; 2016 May; 9(1):61. PubMed ID: 27234294
[TBL] [Abstract][Full Text] [Related]
45. Quantitative evaluation of disease progression in a longitudinal mild cognitive impairment cohort.
Runtti H; Mattila J; van Gils M; Koikkalainen J; Soininen H; Lötjönen J;
J Alzheimers Dis; 2014; 39(1):49-61. PubMed ID: 24121959
[TBL] [Abstract][Full Text] [Related]
46. Plasma RNA sequencing of extracellular RNAs reveals potential biomarkers for non-small cell lung cancer.
Wang L; Wang J; Jia E; Liu Z; Ge Q; Zhao X
Clin Biochem; 2020 Sep; 83():65-73. PubMed ID: 32526228
[TBL] [Abstract][Full Text] [Related]
47. Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer's disease in individuals with subjective cognitive decline.
Stockmann J; Verberk IMW; Timmesfeld N; Denz R; Budde B; Lange-Leifhelm J; Scheltens P; van der Flier WM; Nabers A; Teunissen CE; Gerwert K
Alzheimers Res Ther; 2020 Dec; 12(1):169. PubMed ID: 33357241
[TBL] [Abstract][Full Text] [Related]
48. Plasma Amyloid Concentration in Alzheimer's Disease: Performance of a High-Throughput Amyloid Assay in Distinguishing Alzheimer's Disease Cases from Controls.
Feinkohl I; Schipke CG; Kruppa J; Menne F; Winterer G; Pischon T; Peters O
J Alzheimers Dis; 2020; 74(4):1285-1294. PubMed ID: 32176645
[TBL] [Abstract][Full Text] [Related]
49. Decreased Levels of Blood AMPKα1 but not AMPKα2 Isoform in Patients with Mild Cognitive Impairment and Alzheimer's Disease: A Pilot Study.
Wang X; Zimmermann HR; Lockhart SN; Craft S; Ma T
J Alzheimers Dis; 2020; 76(1):217-224. PubMed ID: 32444538
[TBL] [Abstract][Full Text] [Related]
50. A New Serum Biomarker Set to Detect Mild Cognitive Impairment and Alzheimer's Disease by Peptidome Technology.
Abe K; Shang J; Shi X; Yamashita T; Hishikawa N; Takemoto M; Morihara R; Nakano Y; Ohta Y; Deguchi K; Ikeda M; Ikeda Y; Okamoto K; Shoji M; Takatama M; Kojo M; Kuroda T; Ono K; Kimura N; Matsubara E; Osakada Y; Wakutani Y; Takao Y; Higashi Y; Asada K; Senga T; Lee LJ; Tanaka K
J Alzheimers Dis; 2020; 73(1):217-227. PubMed ID: 31771070
[TBL] [Abstract][Full Text] [Related]
51. Salivary exRNA biomarkers to detect gingivitis and monitor disease regression.
Kaczor-Urbanowicz KE; Trivedi HM; Lima PO; Camargo PM; Giannobile WV; Grogan TR; Gleber-Netto FO; Whiteman Y; Li F; Lee HJ; Dharia K; Aro K; Martin Carreras-Presas C; Amuthan S; Vartak M; Akin D; Al-Adbullah H; Bembey K; Klokkevold PR; Elashoff D; Barnes VM; Richter R; DeVizio W; Masters JG; Wong DTW
J Clin Periodontol; 2018 Jul; 45(7):806-817. PubMed ID: 29779262
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment.
Hansson O; Zetterberg H; Vanmechelen E; Vanderstichele H; Andreasson U; Londos E; Wallin A; Minthon L; Blennow K
Neurobiol Aging; 2010 Mar; 31(3):357-67. PubMed ID: 18486992
[TBL] [Abstract][Full Text] [Related]
53. The evaluation of thiol-disulfıte balance, ischemıa albumın modıfıcation and seruloplazmine as a new oxidatıve stress in mild cognitive impairment and early stage alzheimer's disease patients.
Gündüztepe Y; Bukan N; Zorlu E; Karaman Y; Andaç Topkan T; Gurbuz N; Neşelioğlu S; Erel Ö
J Clin Neurosci; 2020 May; 75():188-194. PubMed ID: 32223973
[TBL] [Abstract][Full Text] [Related]
54. Extracellular RNA in Central Nervous System Pathologies.
Tielking K; Fischer S; Preissner KT; Vajkoczy P; Xu R
Front Mol Neurosci; 2019; 12():254. PubMed ID: 31680858
[TBL] [Abstract][Full Text] [Related]
55. Detection of circulating extracellular mRNAs by modified small-RNA-sequencing analysis.
Akat KM; Lee YA; Hurley A; Morozov P; Max KE; Brown M; Bogardus K; Sopeyin A; Hildner K; Diacovo TG; Neurath MF; Borggrefe M; Tuschl T
JCI Insight; 2019 Apr; 5(9):. PubMed ID: 30973829
[TBL] [Abstract][Full Text] [Related]
56. Plasma Aβ42 as a Biomarker of Prodromal Alzheimer's Disease Progression in Patients with Amnestic Mild Cognitive Impairment: Evidence from the PharmaCog/E-ADNI Study.
Albani D; Marizzoni M; Ferrari C; Fusco F; Boeri L; Raimondi I; Jovicich J; Babiloni C; Soricelli A; Lizio R; Galluzzi S; Cavaliere L; Didic M; Schönknecht P; Molinuevo JL; Nobili F; Parnetti L; Payoux P; Bocchio L; Salvatore M; Rossini PM; Tsolaki M; Visser PJ; Richardson JC; Wiltfang J; Bordet R; Blin O; Forloni G; Frisoni GB;
J Alzheimers Dis; 2019; 69(1):37-48. PubMed ID: 30149449
[TBL] [Abstract][Full Text] [Related]
57. ADAM10 plasma levels predict worsening in cognition of older adults: a 3-year follow-up study.
Oliveira Monteiro MPA; Salheb Oliveira DSM; Manzine PR; Crispim Nascimento CM; Dos Santos Orlandi AA; de Oliveira Gomes GA; Dos Santos Orlandi F; Zazzetta MS; Pott-Junior H; Cominetti MR
Alzheimers Res Ther; 2021 Jan; 13(1):18. PubMed ID: 33419480
[TBL] [Abstract][Full Text] [Related]
58. Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease.
Mattsson N; Andreasson U; Zetterberg H; Blennow K;
JAMA Neurol; 2017 May; 74(5):557-566. PubMed ID: 28346578
[TBL] [Abstract][Full Text] [Related]
59. Local MRI analysis approach in the diagnosis of early and prodromal Alzheimer's disease.
Chincarini A; Bosco P; Calvini P; Gemme G; Esposito M; Olivieri C; Rei L; Squarcia S; Rodriguez G; Bellotti R; Cerello P; De Mitri I; Retico A; Nobili F;
Neuroimage; 2011 Sep; 58(2):469-80. PubMed ID: 21718788
[TBL] [Abstract][Full Text] [Related]
60. Extracellular RNA profiles with human age.
Dluzen DF; Noren Hooten N; De S; Wood WH; Zhang Y; Becker KG; Zonderman AB; Tanaka T; Ferrucci L; Evans MK
Aging Cell; 2018 Aug; 17(4):e12785. PubMed ID: 29797538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
